Expression of alpha(v)beta6 integrin in oral leukoplakia.
about
Molecular imaging of integrin αvβ6 expression in living subjects.A liposomal drug platform overrides peptide ligand targeting to a cancer biomarker, irrespective of ligand affinity or densityIntegrin-mediated regulation of epidermal wound functionsCyclic alphavbeta6-targeting peptide selected from biopanning with clinical potential for head and neck squamous cell carcinoma.Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma.Suppression of αvβ6 Integrin Expression by Polymicrobial Oral Biofilms in Gingival Epithelial CellsUrban legends series: oral leukoplakia.From phage display to nanoparticle delivery: functionalizing liposomes with multivalent peptides improves targeting to a cancer biomarkerCell adhesion molecules and oral cancer.Molecular changes in invasive front of oral cancer.Why integrin as a primary target for imaging and therapy.Progress in determining the malignant potential of oral lesions.Synthesis and biological evaluation of a peptide-paclitaxel conjugate which targets the integrin αvβ₆Alphavbeta6 integrin in wound healing and cancer of the oral cavity.The alphaVbeta6 integrin as a novel molecular target for colorectal cancer.Binding of TGF-beta1 latency-associated peptide (LAP) to alpha(v)beta6 integrin modulates behaviour of squamous carcinoma cells.Epithelial-mesenchymal transition and colorectal cancer: gaining insights into tumor progression using LIM 1863 cells.Signal transduction pathways involved in epithelial-mesenchymal transition in oral cancer compared with other cancers.Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy.Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development.Defining the role of integrin alphavbeta6 in cancer.Epithelial integrins with special reference to oral epithelia.Suppression of integrin alphaupsilonbeta6 by RNA interference in colon cancer cells inhibits extracellular matrix degradation through the MAPK pathway.Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro.AlphaVbeta6 integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9.Oxidative stress induced mechanisms in the progression of periodontal diseases and cancer: a common approach to redox homeostasis?Integrin Regulation of Epidermal Functions in Wounds.Expression of fibronectin-binding integrins in gingival epithelium in drug-induced gingival overgrowth.Integrin expression in colon cancer cells is regulated by the cytoplasmic domain of the beta6 integrin subunit.Head and neck cancer: a screening strategy.Clinical significance of integrin αvβ6 expression effects on gastric carcinoma invasiveness and progression via cancer-associated fibroblasts.Alphavbeta6-Fyn signaling promotes oral cancer progression.Correlation of Vascularization and Inflammation with Severity of Oral Leukoplakia.
P2860
Q27007536-40279D70-D523-449B-AA98-4E51A73422F2Q27308658-1677262D-A82E-4B21-8595-B3723A86CBF7Q28388577-5997486B-1981-4547-BE01-317E113A8632Q33477474-4FF7C48C-233D-4167-ADCB-EA8999327DF7Q33731789-390F92FD-C325-44CE-9E9B-0B56F0954296Q33861151-43839DB4-CC1B-4D29-A96F-9BA55D098794Q34326109-ECCB5EB2-79D0-425D-9938-345C2CB2FB45Q34491680-A41F1328-B5AD-44C2-B755-EADD16FEB9B0Q34503793-CD9BBA00-3FAC-4B4F-986F-84CA5796F947Q34657627-ABFFEFC6-BB44-4340-8F2F-92DA95ACB629Q34912582-A3D94734-9329-4FE9-8C2F-E48EBCDF022CQ35106813-57170CA8-284C-4B04-B6DE-131406A2426CQ35368323-94E98983-44AA-43AE-9BCD-9B352E804FBEQ36360521-4265CC9A-3988-4CAC-A329-CBE3FA421608Q36429644-3A29C3E1-87EE-45C9-8F45-EE377A8B5B09Q36646138-30679D3D-DE33-4D9D-9DA0-FE5C9C2F6C21Q36857749-A2D81B04-4347-477F-8B12-6A91A60C6722Q36857755-7AD4D569-19E0-47BC-862A-09130284E182Q37039386-BC5A7732-7E39-4A15-8090-04763E8F475EQ37089026-9C144821-2040-40F5-BC12-2F619CDC9121Q37550644-E5E43F19-8D20-4CD5-9009-FB4B39860BACQ37858271-26B44B8E-E831-4638-9936-729192A73AB5Q39970189-2DAE1FE7-97E5-4FA3-A160-84B4CCFEDB82Q40522209-87C7AA3D-C000-406A-B30B-4111528E5BAAQ40807777-465171BF-C82A-4818-B584-E267554096DAQ41830016-9C5364C5-E40B-4FBB-A22A-A7564CC1A1FFQ42409259-B332B181-FA72-4238-80A3-B22F107E151BQ42508444-BC3413AA-E267-442E-9603-4D533D29A3CDQ43981224-5119A70B-CEC0-45C7-874E-F5833AFAC6A2Q44033141-D2C0C7E4-8BF5-4B27-9923-9E66D7B32EBCQ45748100-506E4147-81DD-4BC3-AE44-8E378C83BD7AQ45948340-44DA9958-E494-4185-BE69-B3AC3E35630DQ55256550-215C2FD6-F01B-4B95-837A-D6C445F07309
P2860
Expression of alpha(v)beta6 integrin in oral leukoplakia.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Expression of alpha(v)beta6 integrin in oral leukoplakia.
@en
type
label
Expression of alpha(v)beta6 integrin in oral leukoplakia.
@en
prefLabel
Expression of alpha(v)beta6 integrin in oral leukoplakia.
@en
P2093
P2860
P356
P1476
Expression of alpha(v)beta6 integrin in oral leukoplakia.
@en
P2093
P2860
P2888
P304
P356
10.1054/BJOC.1999.1130
P407
P577
2000-04-01T00:00:00Z
P5875
P6179
1046459738